Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?
Publication
, Journal Article
Greenberg, A
Published in: Am J Kidney Dis
December 2007
Duke Scholars
Published In
Am J Kidney Dis
DOI
EISSN
1523-6838
Publication Date
December 2007
Volume
50
Issue
6
Start / End Page
904 / 907
Location
United States
Related Subject Headings
- Urology & Nephrology
- Treatment Outcome
- Tolvaptan
- Receptors, Vasopressin
- Randomized Controlled Trials as Topic
- Humans
- Heart Failure
- Benzazepines
- Antidiuretic Hormone Receptor Antagonists
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Greenberg, A. (2007). Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure? Am J Kidney Dis, 50(6), 904–907. https://doi.org/10.1053/j.ajkd.2007.10.006
Greenberg, Arthur. “Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?” Am J Kidney Dis 50, no. 6 (December 2007): 904–7. https://doi.org/10.1053/j.ajkd.2007.10.006.
Greenberg A. Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure? Am J Kidney Dis. 2007 Dec;50(6):904–7.
Greenberg, Arthur. “Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?” Am J Kidney Dis, vol. 50, no. 6, Dec. 2007, pp. 904–07. Pubmed, doi:10.1053/j.ajkd.2007.10.006.
Greenberg A. Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure? Am J Kidney Dis. 2007 Dec;50(6):904–907.
Published In
Am J Kidney Dis
DOI
EISSN
1523-6838
Publication Date
December 2007
Volume
50
Issue
6
Start / End Page
904 / 907
Location
United States
Related Subject Headings
- Urology & Nephrology
- Treatment Outcome
- Tolvaptan
- Receptors, Vasopressin
- Randomized Controlled Trials as Topic
- Humans
- Heart Failure
- Benzazepines
- Antidiuretic Hormone Receptor Antagonists
- 3202 Clinical sciences